Avid Bioservices, Inc. revenue increases to $149.27 million in 2023 from previous year
By USInMinutes - Jun 21, 2023, 06:52 PM ET
Last Updated - Jul 18, 2023, 03:07 PM EDT
Key fundamental financials
profit of $560,000
Revenue of $149.27 million
earnings per share of $0.01
Current Reporting
Revenue
Net Income
Profit/Loss
Apr 2023
$149.27 million
$560,000
profit
Apr 2022
$119.60 million
$127.67 million
profit
Apr 2021
$95.87 million
$11.21 million
profit
Avid Bioservices, Inc. [CDMO] has reported $560,000 profit for the fiscal year ending Apr 30, 2023 while the earnings for the same period were $0.01 per share.
Revenue for the year was $149.27 million with operating income of $3.60 million.
The Tustin, California (CA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $189.47 million.
